By Drug Target Review2024-01-10T16:00:50
Novel self-assembled amino acid-based nanoparticles, loaded with doxorubicin, could evolve cancer treatment.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-30T09:54:00Z
2026-03-26T13:58:00Z
2026-03-18T14:47:08Z
2023-03-20T13:41:33
Sponsored by Bio-Techne
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2024-01-24T12:52:38
Sponsored by BellBrook Labs
Site powered by Webvision Cloud